European Journal of Medicinal Chemistry p. 321 - 326 (1995)
Update date:2022-09-26
Topics:
Komiotis, D.
Pananookooln, S.
Zaw, K.
Dieter, J. P.
Breton, G. C. Le
Venton, D. L.
The title compounds have been synthesized and their in vitro thromboxane A2(TxA2) receptor antagonist activity evaluated.Both cis and trans isomers (1,2) were shown to specifically inhibit submaximal human platelet aggregation induced by 225 nM U46619 in a dose-dependent manner with an IC50 of 1 μM.The concentration of 1 and 2 required to completely block maximal aggregation induced by 3 μM U46619 was 3 μM. thromboxane A2/ receptor antagonist/ platelet aggregation/ 1,3-dioxolane
View MoreContact:86-512-87182055
Address:No.128 Fangzhou Rd, Suzhou Industrial Park, China, 215125, China
Jiangsu Haian Petro chemical Plant
Contact:+86-513-88902723
Address:99, Changjiang West Road, Haian County, Jiangsu
SJZ Chenghui Chemical Co., Ltd.
Contact:86-311-87713916
Address:no.368 youyi north avenue
Contact:(86) 731 88718666
Address:Room 1222, Unit 4, Building B, Shangcheng, No.47, Kaiyuan East Road.
Disynthesis Chemical Technology Co. Ltd.
Contact:+86-571-88194596
Address:Dengyun road 380, Gongshu district, Hangzhou city, China
Doi:10.1016/S0040-4039(00)85246-6
(1986)Doi:10.1039/c39900000897
(1990)Doi:10.1039/c2ob06934b
(2012)Doi:10.1007/BF00487436
(1990)Doi:10.1021/ol2011067
(2011)Doi:10.1016/0022-328X(86)82021-6
(1986)
